October 16, 2020
Agios Pharmaceuticals
Agios Announces Withdrawal of European Marketing Authorization Application for TIBSOVO® as a Treatment for Relapsed or Refractory IDH1-mutant Acute Myeloid Leukemia
October 15, 2020
Sage Therapeutics
Sage Therapeutics Announces Positive Interim, Topline Zuranolone Safety and Tolerability Data from Open-Label SHORELINE Study in Patients with MDDs
October 14, 2020
Ambys Medicines
Ambys Medicines Expands Board of Directors with Appointment of Jennifer Cook
October 14, 2020
Goldfinch Bio
Goldfinch Bio Honored by Goldman Sachs for Entrepreneurship
October 13, 2020
Cedilla Therapeutics
Cedilla Therapeutics Announces $57.6 Million Series B Financing